Mark Markowski

Disclosure information not submitted.

Presentation(s):

• MP27-15: Sabizabulin has both cytotoxic and cytostatic activity in Phase 1b/2 clinical of men with metastatic castration resistant prostate cancer who progressed on androgen receptor targeting agents

  Saturday, May 14, 2022
  10:30 AM – 11:45 AM